Huberman M - Search Results

1

Correcting for exposure measurement error in uranium miners studies: impact on inverse dose-rate effects.

Stram DO, Huberman M, Langholz B. Stram DO, et al. Among authors: huberman m. Radiat Res. 2000 Dec;154(6):738-9;discussion 739-40. Radiat Res. 2000. PMID: 11187025 No abstract available.

2

Correcting for exposure measurement error in a reanalysis of lung cancer mortality for the Colorado Plateau Uranium Miners cohort.

Stram DO, Langholz B, Huberman M, Thomas DC. Stram DO, et al. Among authors: huberman m. Health Phys. 1999 Sep;77(3):265-75. doi: 10.1097/00004032-199909000-00004. Health Phys. 1999. PMID: 10456497

3

Is residual confounding a reasonable explanation for the apparent protective effects of beta-carotene found in epidemiologic studies of lung cancer in smokers?

Stram DO, Huberman M, Wu AH. Stram DO, et al. Among authors: huberman m. Am J Epidemiol. 2002 Apr 1;155(7):622-8. doi: 10.1093/aje/155.7.622. Am J Epidemiol. 2002. PMID: 11914189

4

Application of the missing-indicator method in matched case-control studies with incomplete data.

Huberman M, Langholz B. Huberman M, et al. Am J Epidemiol. 1999 Dec 15;150(12):1340-5. doi: 10.1093/oxfordjournals.aje.a009966. Am J Epidemiol. 1999. PMID: 10604777

5

Ascertainment bias in rate ratio estimation from case-sibling control studies of variable age-at-onset diseases.

Langholz B, Ziogas A, Thomas DC, Faucett C, Huberman M, Goldstein L. Langholz B, et al. Among authors: huberman m. Biometrics. 1999 Dec;55(4):1129-36. doi: 10.1111/j.0006-341x.1999.01129.x. Biometrics. 1999. PMID: 11315058

6

Nonrandomized comparison of surgery with and without adjuvant pelvic irradiation for patients with pT3N0 adenocarcinoma of the prostate.

Petrovich Z, Lieskovsky G, Langholz B, Huberman M, Streeter O, Skinner DG. Petrovich Z, et al. Among authors: huberman m. Am J Clin Oncol. 2001 Dec;24(6):537-46. doi: 10.1097/00000421-200112000-00002. Am J Clin Oncol. 2001. PMID: 11801750

7

Re: "Combined analysis of matched and unmatched case-control studies: comparison of risk estimates from different studies".

Huberman M, Langholz B. Huberman M, et al. Am J Epidemiol. 1999 Jul 15;150(2):219-20. doi: 10.1093/oxfordjournals.aje.a009987. Am J Epidemiol. 1999. PMID: 10412970 No abstract available.

8

Comparison of surgery alone with surgery and adjuvant radiotherapy for pT3N0 prostate cancer.

Petrovich Z, Lieskovsky G, Stein JP, Huberman M, Skinner DG. Petrovich Z, et al. Among authors: huberman m. BJU Int. 2002 Apr;89(6):604-11. doi: 10.1046/j.1464-410x.2002.02698.x. BJU Int. 2002. PMID: 11942974

9

Determinants of tumor response and survival with erlotinib in patients with non--small-cell lung cancer.

Pérez-Soler R, Chachoua A, Hammond LA, Rowinsky EK, Huberman M, Karp D, Rigas J, Clark GM, Santabárbara P, Bonomi P. Pérez-Soler R, et al. Among authors: huberman m. J Clin Oncol. 2004 Aug 15;22(16):3238-47. doi: 10.1200/JCO.2004.11.057. J Clin Oncol. 2004. PMID: 15310767 Clinical Trial.

10

Cisplatin and chronic oral etoposide as salvage therapy for advanced colorectal carcinoma.

Stuart K, Posner M, Campbell K, Huberman M. Stuart K, et al. Among authors: huberman m. Am J Clin Oncol. 1995 Aug;18(4):300-2. doi: 10.1097/00000421-199508000-00006. Am J Clin Oncol. 1995. PMID: 7625370 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

139 results

Search Page

Filters